Mohammad El-Kalay

457 total citations
8 papers, 291 citations indexed

About

Mohammad El-Kalay is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mohammad El-Kalay has authored 8 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Mohammad El-Kalay's work include Pluripotent Stem Cells Research (3 papers), Mesenchymal stem cell research (3 papers) and CAR-T cell therapy research (3 papers). Mohammad El-Kalay is often cited by papers focused on Pluripotent Stem Cells Research (3 papers), Mesenchymal stem cell research (3 papers) and CAR-T cell therapy research (3 papers). Mohammad El-Kalay collaborates with scholars based in United States, Australia and Israel. Mohammad El-Kalay's co-authors include Onanong Chivatakarn, Marie‐Françoise Chesselet, Marina Romero‐Ramos, Patrick Vourc’h, Paul A. Lucas, Warren Young, Dennis J. Carlo, Jeffrey Encinas, Ronald B. Moss and Thomas Moll and has published in prestigious journals such as Blood, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Mohammad El-Kalay

6 papers receiving 274 citations

Peers

Mohammad El-Kalay

MB

GENET

SURGE

DN

IMMUN

Chen Qiu China

T. Schweitzer Germany

Qin Yu China

Daisuke Kanematsu Japan

Bogna Badyra Poland

Jingxia Yu China

W. Barada Lebanon

Pavla Boháčová Czechia

Fengming Yue Japan

Yasutaka Yamauchi Japan

Chen Qiu China

Mohammad El-Kalay

110 ×0.7

MB

77 ×0.8

GENET

112 ×1.5

SURGE

16 ×0.3

DN

49 ×1.0

IMMUN

Citations per year, relative to Mohammad El-Kalay Mohammad El-Kalay (= 1×) peers Chen Qiu

Countries citing papers authored by Mohammad El-Kalay

Since Specialization

Citations

This map shows the geographic impact of Mohammad El-Kalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad El-Kalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad El-Kalay more than expected).

Fields of papers citing papers by Mohammad El-Kalay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad El-Kalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad El-Kalay. The network helps show where Mohammad El-Kalay may publish in the future.

Co-authorship network of co-authors of Mohammad El-Kalay

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad El-Kalay. A scholar is included among the top collaborators of Mohammad El-Kalay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad El-Kalay. Mohammad El-Kalay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bernareggi, Davide, Caryn S. Gonsalves, Luis A. Solchaga, et al.. (2022). Abstract 3151: A novel method to produce clinical scale induced pluripotent stem cell-derived natural killer (iPSC-NK) cells with improved anti-tumor activity for next-generation allogenic cell therapies. Cancer Research. 82(12_Supplement). 3151–3151.

2.

Bernareggi, Davide, et al.. (2022). 336 A novel method for efficient cGMP production of natural killer cells from clonal master induced pluripotent stem cells for next generation, off-the-shelf cancer immunotherapy. Regular and Young Investigator Award Abstracts. A354–A354. 1 indexed citations

3.

El-Kalay, Mohammad, et al.. (2022). A Novel Method for Efficient cGMP Production of Natural Killer Cells from Clonal Master Induced Pluripotent Stem Cells for Next Generation, Off-the-Shelf Cancer Immunotherapy. Blood. 140(Supplement 1). 1613–1614.

4.

Friedlander, Martin, Michael I. Dorrell, Matthew R. Ritter, et al.. (2007). Progenitor cells and retinal angiogenesis. Angiogenesis. 10(2). 89–101. 51 indexed citations

5.

Moss, Ronald B., et al.. (2004). Th1/Th2 cells in inflammatory disease states: therapeutic implications. Expert Opinion on Biological Therapy. 4(12). 1887–1896. 72 indexed citations

6.

Vourc’h, Patrick, Marina Romero‐Ramos, Onanong Chivatakarn, et al.. (2004). Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. Biochemical and Biophysical Research Communications. 317(3). 893–901. 43 indexed citations

7.

Romero‐Ramos, Marina, Patrick Vourc’h, Warren Young, et al.. (2002). Neuronal differentiation of stem cells isolated from adult muscle. Journal of Neuroscience Research. 69(6). 894–907. 121 indexed citations

8.

Daculsi, G., et al.. (2000). OSTEOGENIC ACTIVITY OF HUMAN MESENCHYMAL STEM CELLS IN VIVO ON CALCIUM PHOSPHATE CERAMICS. ASAIO Journal. 46(2). 238–238. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact